Daten zu öffentlichen Aufträgen und Fördermitteln in Europa aus amtlichen Registern · Datenstand: 17. November 2026, tägliche Aktualisierung.

Förderprogramm · Vereinigte Staaten

National Center on Sleep Disorders Research

National Center on Sleep Disorders Research (Vereinigte Staaten): Aufrufe und Förderungen des Programms. 81 Aufrufe auf der Seite, davon 25 offen; Aufrufe starten meist im November. Datenstand: 17. November 2026, tägliche Aktualisierung.

Fördergeber: National Institutes of Health (Department of Health and Human Services)

Förderungen der letzten 24 Monate
0
Empfänger
0
Offene Aufrufe
25
Aufrufe auf der Seite
81

Aufrufe starten meist im November

Über das Programm

Objectives: The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more…

Mehr in der Quelle

Offene Aufrufe

FörderaufrufStatusFrist
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) (Runde 12.2024 – 02.2027)Offen3. Februar 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) (Runde 12.2024 – 02.2027)Offen3. Februar 2027
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)Offen10. März 2027
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) (Runde 12.2024 – 03.2027)Offen16. März 2027
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) (Runde 04.2024 – 04.2027)Offen28. April 2027
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) (Runde 04.2024 – 04.2027)Offen28. April 2027
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) (Runde 07.2024 – 07.2027)Offen12. Juli 2027
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) (Runde 07.2024 – 07.2027)Offen12. Juli 2027
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) (Runde 12.2024 – 09.2027)Offen7. September 2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)Offen18. November 2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)Offen23. Dezember 2027
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) (Runde 11.2024 – 12.2027)Offen23. Dezember 2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)Offen23. Dezember 2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)Offen23. Dezember 2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)Offen23. Dezember 2027
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) (Runde 09.2025 – 05.2028)Offen8. Mai 2028
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)Offen9. Oktober 2028
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) (Runde 10.2026 – 10.2028)Offen13. Oktober 2028
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) (Runde 03.2026 – 11.2028)Offen2. November 2028
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) (Runde 03.2026 – 11.2028)Offen2. November 2028
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) (Runde 03.2026 – 11.2028)Offen2. November 2028
Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) (Runde 05.2026 – 11.2028)Offen7. November 2028
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)Offen5. April 2029
Implementation and Evaluation of Databases to Examine AIDSGeplant—
Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)Geplant—

Frühere Aufrufe

Förderkalender

Förderungen für Projekte mit Beginn zwischen 17. November 2024 und 17. November 2026; Beträge in Euro zum Eurostat-Kurs des jeweiligen Jahres.

Fragen und Antworten

National Center on Sleep Disorders Research: Wann starten die Förderaufrufe?
Derzeit offen (25): NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders… (3. Februar 2027), NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders… (3. Februar 2027), Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U… (10. März 2027), …. Aufrufe starten meist im November.